CYCN

CYCLERION THERAPEUTICS, INC.

CYCN · CIK 1755237 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$2M
20192024
Net Income−$3M
20192024
Operating CF−$4M
20192024
Free Cash Flow
20192024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue——————
Gross Profit——————
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.1B$0.1B
SG&A Expense——————
Operating Income$-0.0B$-0.0B$-0.0B$-0.1B$-0.1B$-0.1B
Net Income$-0.0B$-0.0B$-0.0B$-0.1B$-0.1B$-0.1B
EPS (Basic)$-1.21$-2.25$-1.01———
EPS (Diluted)$-1.21$-2.25$-1.01———

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$0.0B$0.0B$0.0B$0.1B$0.1B$0.2B
Current Assets$0.0B$0.0B$0.0B$0.1B$0.1B$0.1B
Cash & Equivalents$0.0B$0.0B$0.0B$0.1B$0.1B$0.1B
Total Liabilities——————
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.0B$0.0B$0.0B$0.1B$0.1B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.1B$-0.1B
Investing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.0B$-0.0B
Capital Expenditures——$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.0B$0.2B
← Companies